Brain & Neurology
-
UK-wide motor neuron disease project
A major new project into treatments for motor neuron disease has received substantial funding from a group of charities and government research organisations. Read more
-
Cancer technique might diagnose early Alzheimer’s disease
Adapting an algorithm used to classify cancer tumours can help to diagnose Alzheimer’s disease at an earlier stage, according to a new study. Read more
-
Treatment hope for cognitive symptoms in Parkinson’s disease
Ultra-powerful 7T MRI scanners could help to identify those patients with conditions such as Parkinson’s disease who would benefit from new treatments for cognitive symptoms that were previously untreatable, British researchers report today. Read more
-
Heat shock clue to preventing dementia
Heat shock proteins may play a key role in preventing dementia, helping to explain reports that sauna use reduces risk, according to British scientists. Read more
-
How healthy lifestyle ‘delays Alzheimer’s’
A healthy lifestyle, combining physical and cognitive exercise with a good diet, can help reduce the risk of dementia, according to joint research by teams from Switzerland and the USA. Read more
-
Protein could be key to preventing Parkinson’s disease
A protein could play a vital protective role against Parkinson’s disease, a Swiss study has found. Read more
-
No increased risk of neurological events after COVID vaccination
There is no increased risk of rare neurological events following COVID-19 vaccination, according to new evidence published today. Read more
-
Extended group of early Parkinson’s signs discovered
People present a broad range of symptoms up to a decade before Parkinson’s disease is diagnosed, with tremor and memory symptoms being the most prominent, according to a new analysis. Read more
-
Guillain-Barre linked to cancer
A possible link has been discovered between certain cancers and the rare neurologic disorder Guillain-Barre syndrome. Read more
-
Genetic variant behind more serious disease outcomes
Scientists have explained why a common genetic variant worsens disease outcomes for people with adult-onset neurodegenerative diseases, it has been announced. Read more
